Change over period: —
NSE · ARVEE
Arvee Laboratories (India) Ltd
-29.3% from the 52-week high · +53.5% above the low
Arvee Laboratories (India) Ltd. provides chemical products, which includes polymer modifiers, contrast media and drug intermediates. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2018-02-22. The firm is primarily engaged in the manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The Company’s Polymer Modifiers include 5-Sulfoisophthalic Acid Mono Sodium Salt, Dimethyl 5-Sodiosulfoisophthalate and 5-Sulfoisophthalic Acid Mono Lithium Salt. Its Contrast Media Intermediates include 5-Nitroisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, Monomethyl 5-Nitroisophthalate, 3,5-Diamino Benzoic Acid, Dimethyl 5-Aminoisophthalate and 3,5-Dinitrobenzoic acid. Its Drug Intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
The short version. Promoter holding was 73.5% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
Arvee Laboratories (India) Ltd trades 29.3% below its 52-week high and 53.5% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 | 0.0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 | 0.0 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for Arvee Laboratories (India) Ltd are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about Arvee Laboratories (India) Ltd
What is the Arvee Laboratories (India) Ltd share price?
Arvee Laboratories (India) Ltd (ARVEE) last closed at ₹203.00, down 1.23% on the day. Its 52-week range is ₹133.86 to ₹290.78.
What is the market cap of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd has a market capitalisation of about ₹226 crore. Its price-to-earnings ratio is 34.4.
How are Arvee Laboratories (India) Ltd's latest results?
Promoter holding was 73.5% in Sep 2026, up 0.00 points over 8 quarters.
Who owns Arvee Laboratories (India) Ltd?
As of Sep 2026, shareholding was: Promoter 73.5%, Public 26.5%.
How many mutual funds hold Arvee Laboratories (India) Ltd?
0 mutual fund schemes held Arvee Laboratories (India) Ltd in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 13 Oct 2020 · Bonus issue 1:1
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.